Carl H. Samuelsen
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Exploring Patient Perspectives on Upper Tract Urothelial Cancer: A Qualitative Interview Study.
Journal: Oncology and therapy
Published: November 11, 2025
Emotional reactions to infertility diagnosis: thematic and natural language processing analyses of the 1000 Dreams survey.
Journal: Reproductive biomedicine online
Published: April 19, 2022
How Do People with Experience of Infertility Value Different Aspects of Assistive Reproductive Therapy? Results from a Multi-Country Discrete Choice Experiment.
Journal: The patient
Published: November 09, 2021
Tailored support may reduce mental and relational impact of infertility on infertile patients and partners.
Journal: Reproductive biomedicine online
Published: September 30, 2021
Barriers and factors associated with significant delays to initial consultation and treatment for infertile patients and partners of infertile patients.
Journal: Reproductive biomedicine online
Published: May 21, 2021
Is the public supportive and willing to pay for a national assistive reproductive therapies programme? Results from a multicountry survey.
Journal: BMJ open
Published: March 11, 2021
Network meta-analyses for EGFR mutation-positive non-small-cell lung cancer: systematic review and overview of methods and shortcomings.
Journal: Journal of comparative effectiveness research
Published: October 28, 2020
Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: September 06, 2019
Healthcare resource utilization and costs associated with patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive NSCLC in the United States.
Journal: Journal of medical economics
Published: July 18, 2019
Duration of treatment among patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive non-small-cell lung cancer in the USA.
Journal: Future oncology (London, England)
Published: March 20, 2019
First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 25, 2019
Influenced from the start: anchoring bias in time trade-off valuations.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: March 04, 2016
Last Updated: 09/26/2026